Femasys Logo
Main Menu

Resources

Find the latest news about Femasys, including our media mentions, scientific publications, and more.

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

Femasys Shareholder Update – Q1 2026

  • Femasys

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

Intratubal insemination success, at age 39 – Aslyn’s story

  • The Ribbon Box

From Lab to Life the Journey Behind Solving Womens Healthcare

  • Influential Women Podcast

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

  • GlobeNewswire
Load More

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

Femasys Shareholder Update – Q1 2026

  • Femasys

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

Intratubal insemination success, at age 39 – Aslyn’s story

  • The Ribbon Box

From Lab to Life the Journey Behind Solving Womens Healthcare

  • Influential Women Podcast

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

  • GlobeNewswire

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

  • GlobeNewswire

Scott Chudnoff, MD, highlights the benefits of Fembloc for permanent contraception

  • Contemporary OB/GYN

Femasys Announces Third Quarter Financial Results for 2025

  • GlobeNewswire

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

  • GlobeNewswire

How Femasys Is Using Innovation to Rethink Permanent Birth Control

  • MedTech Spectrum

FDA grants IDE approval for FemBloc nonsurgical permanent birth control

  • Contemporary OB/GYN
Load More

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

  • GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

  • GlobeNewswire

Innovation in Women’s Reproductive Health is More Important than Ever

  • Medical Design & Development

Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment

  • Femtech Insider

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

  • GlobeNewswire

Femasys secures CE mark certification for FemVue MINI solution

  • Medical Device Network
Load More

From Lab to Life the Journey Behind Solving Womens Healthcare

  • Influential Women Podcast

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

  • Health Innovation Matters

Intratubal insemination: Another Option in Fertility Treatment

  • Fertility Docs Uncensored

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

  • Empowered Patient Podcast

VIDEO: President and CEO, Kathy Lee-Sepsick speaks to connecting with the audience

  • YouTube

VIDEO: President and CEO, Kathy Lee-Sepsick at SLS

  • YouTube
Load More

Media Kits

For additional information, please email [email protected]

Corporate Kit

Infertility Kit

Contraception Kit

Biopsy Kit

About Femasys
Investor Relations
Resources
Contact Us
Healthcare Professionals
Patients
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu